Last updated on March 2018

A clinical trial to evaluate treatments using salmeterol/fluticasone, QVM149, QMF149 for patients

Brief description of study

The purpose of the trial is to evaluate the efficacy and safety of two different doses of QVM149 (QVM149 150/50/80 g and QVM149 150/50/160 g via Concept1) over two respective QMF149 doses (QMF149 150/160 g and QMF149 150/320 g via Concept1 in poorly controlled asthmatics as determined by pulmonary function testing and effects on asthma control.

Clinical Study Identifier: NCT02571777

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Kanpur, India
  Connect »